Drugs
-
Adderall and Adderall XR (amphetamines) Information
Adderall and Adderall XR are medications used to treat attention-deficit/hyperactivity disorder (ADHD).
Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax, using the contact information at the bottom of this page.
-
Related Information
Information about Medications Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD) FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults
12/12/2011FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
11/1/2011Communication about an Ongoing Safety Review of Stimulant Medications used in Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
Issued 6/23/2009; updated 4/2011FDA Asks Attention-Deficit Hyperactivity Disorder (ADHD) Drug Manufacturers to Develop Patient Medication Guides
Issued 2/21/2007Information for Healthcare Professionals: Adderall and Adderall XR (amphetamine)
2/2005; updated 8/2005Public Health Advisory for Adderall and Adderall XR
Issued 2/9/2005- FDA Statement on Adderall
Issued 2/9/2005
-
-
Labeling and Regulatory History from Drugs@FDA
Labeling for Adderall from Drugs@FDA Labeling for Adderall Labeling for Adderall XR from Drugs@FDA Labeling for Adderall XR
-
Contact FDA
1-800-332-1088
1-800-FDA-0178 Fax
Report a Serious Problem
Regular Mail: Use postage-paid FDA Form 3500
Mail to: MedWatch 5600 Fishers Lane
Rockville, MD 20857
-
-
